Mount Sinai leads unprecedented attempt to discover rules for assembling human tissue
September 24, 2009Researchers from Mount Sinai School of Medicine and two other academic institutions have received federal funding to systematically assemble functional human kidney tissue from tissue modeled on a computer. If successful, the research—which ties together several emerging technologies including virtual tissue modeling and nanofabrication—could lead to a more predictable way for researchers to engineer tissue outside the body and, consequently, to screen for new drugs.
To fund the project, called Dynamics Underlying Tissue Integrity, the National Institutes of Health (NIH) awarded a five-year, $6-million grant from its Transformative Research Projects (T-R01) program. T-R01 is a new program designed to support exceptionally innovative research initiatives whose anticipated outcomes have a major impact on broad, important problems in biomedical and/or behavioral research. T-R01 awardees—42 total this year—receive part of their funding from the American Recovery and Reinvestment Act.
The leader for this multi-principal investigator project, Ravi Iyengar, PhD, Director of the Experimental Therapeutics Institute (ETI) at Mount Sinai School of Medicine, said creation of a device for assembling tissue will require his team to solve a problem that has existed since pathologists first began examining human cells under microscopes.
"Pathologists typically characterize disease in patients by studying the shape of cells and tissues, and their diagnosis has always been largely empirical," said Dr. Iyengar, who is also Dorothy H. and Lewis Rosenstiel Professor and Chair, Pharmacology and Systems Therapeutics, and Professor of Oncological Sciences and Psychiatry, Mount Sinai School of Medicine. "No one knows why cell shapes change or the rules by which tissues are organized. We want to start getting a handle on this by studying the kidney, and doing that will require the collaboration of several different disciplines."
The scientists plan to focus on the podocyte, a specialized kidney cell that sits on the organ's basement membrane and controls the filtration of small molecules from proteins. A breach in this filtration barrier is a main cause of kidney disease that often occurs among patients with diabetes, HIV, and hypertension. African-Americans with hypertension are four times more likely than whites with hypertension to develop kidney disease, a condition that currently has no cure and can eventually necessitate dialysis.
According to Dr. Iyengar, discovering the tenets underlying tissue assembly, as he and colleagues plan to do here, and having a more predictable method for assembling tissues within a nanofabricated device, would have broad clinical impact. "Lack of engineered tissue devices in vitro, or outside the cell body, is a big impediment in testing new drugs," he said. "If this experiment works and we have a methodology to assemble these tissues within nanofabricated devices, this could become a very useful screening approach for discovery of new drugs for kidney disease."
"The efforts of Dr. Iyengar's team to better understand kidney function at the cellular level will aid therapeutics research," said Dennis S. Charney, MD, the Anne and Joel Ehrenkranz Dean of Mount Sinai School of Medicine and Executive Vice President for Academic Affairs at The Mount Sinai Medical Center. "Mount Sinai, whose infrastructure is designed to foster translational research, is tailor made for collaborative research projects such as this."
Much of the research will take place at the ETI, Mount Sinai's hub for developing new drugs and devices through integrating many facets of therapeutics research, and the NIGMS funded Systems Biology Center New York (SBCNY), which Dr. Iyengar also directs and which is also based at Mount Sinai. SBCNY researchers study at a systems level the molecular interactions within cells and their connection to the physiological function of tissues and organs.
"Dr. Iyengar has seized upon an extraordinary opportunity—the ability to harness systems biology to facilitate the development of new drugs and diagnostic tools," said Kenneth L. Davis, MD, President and CEO of The Mount Sinai Medical Center. "His work has the potential to create a new scientific paradigm."
The other principal investigators from Mount Sinai include John Cijiang He, MD, PhD, Associate Professor of Medicine and Nephrology and Assistant Professor of Pharmacology and Systems Therapeutics, and Susana Neves, PhD, Postdoctoral Fellow in the Department of Pharmacology and Systems Therapeutics.
Two other principal investigators sharing in the grant and lending their expertise are James C. Hone, PhD, of Columbia University, who will design and fabricate the micro- or nanometer-scale devices, and Leslie M. Loew, PhD, who pioneered the development of a computational modeling platform at the University of Connecticut Health Center called the Virtual Cell. Dr. Loew will develop computational models of how cells interact within kidney tissues.
These computational models, or virtual tissue, will form the basis for designing the device for recreating kidney function. The hope is to learn the rules of tissue organization as the team refines the device through testing the computer models and imaging the flow of cell signals within the reassembled tissue from both mouse and human cells.
Commenting on the grant, Francis S. Collins, MD, PhD, Director of the NIH, said the T-R01 program "is intended to support research that has the potential to transform the way we think about and conduct science, so the recipients represent an elite few with truly bold ideas. Competition for the awards was fierce, and standards very high."
Source: The Mount Sinai Hospital
-
New research tracks effects of addictive drugs on brain
May 16, 2008 |
not rated yet |
0
-
Medical journal to be re-launched
Sep 20, 2006 |
not rated yet |
0
-
Mount Sinai first in nation to ablate atrial fibrillation using new visually-guided balloon catheter
Sep 18, 2009 |
not rated yet |
0
-
Researchers discover technology that silences genes
Aug 18, 2008 |
not rated yet |
0
-
New York colleges propose stem cell fund
Feb 08, 2006 |
not rated yet |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (33) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (5) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (2) |
0
-
Is Everyday Technology Killing Us?
Feb 08, 2012
-
Exercise and weight loss
Feb 08, 2012
-
Why do we have head aches? Our brains can't feel anything.
Feb 07, 2012
-
"The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
Feb 04, 2012
-
Oncolytic adenovirus
Feb 04, 2012
-
Nutrition label stuffs and diets
Feb 02, 2012
- More from Physics Forums - Medical Sciences
More news stories
Cognitive impairment in older adults often unrecognized in the primary care setting
A new study published in the Journal of the American Geriatrics Society reveals that brief cognitive screenings combined with offering further evaluation increased new diagnoses of cognitive impairment in older veterans two to ...
1 hour ago |
not rated yet |
0
Botox developer rues missing out on billions
Botox developer Alan Scott says he rues the day he handed over rights to the best-selling wrinkle-smoothing drug to a US company for just $4.5 million, saying he might have become a billionaire.
Medicine & Health / Medications
2 hours ago |
not rated yet |
0
Primary care program helps obese teen girls manage weight, improve body image and behavior
Teenage girls gained less weight, improved their body image, ate less fast food, and had more family meals after participating in a 6- month program that involved weekly peer meetings, consultations with primary care providers ...
1 hour ago |
not rated yet |
0
Young adults allowed to stay on parents' health insurance have improved access to care
Researchers from Mount Sinai School of Medicine have found that laws permitting children to stay on their parents' health insurance through age 26 result in improved access to health care compared to states without those ...
2 hours ago |
not rated yet |
0
Cancer rate 4 times higher in children with juvenile arthritis
New research reports that incident malignancy among children with juvenile idiopathic arthritis (JIA) is four times higher than in those without the disease. Findings now available in Arthritis & Rheumatism, a journal publis ...
2 hours ago |
not rated yet |
0
Ordered planar polymers created for the first time
(PhysOrg.com) -- Scientists under the direction of ETH Zurich have created a minor sensation in synthetic chemistry. They succeeded for the first time in producing regularly ordered planar polymers that form ...
New European rocket lifts off on maiden flight
A new lightweight rocket, Vega, lifted off from Europe's space base Monday carrying nine satellites on its inaugural flight, mission control said.
Hacker claims porn site users compromised
A hacker claims to have compromised the personal information of more than 350,000 users after breaking into a disused website operated by pornography provider Brazzers.
Chinese city seizes Apple iPads in name dispute
(AP) -- Authorities have seized Apple iPads from retailers in a city in northern China due to a dispute with a domestic company that says it owns the iPad name, an official said Monday. The Chinese company said it is asking ...
Microsoft India retail site down after 'cyber attack'
Microsoft India's retail website was down on Monday after reportedly being hacked by a Chinese group calling itself Evil Shadow Team.
Rapunzel, Leonardo and the physics of the ponytail
(PhysOrg.com) -- New research provides the first mathematical understanding of the shape of a ponytail and could have implications for the textile industry, computer animation and personal care products.